An Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease

Rutgeerts, P. (1998). The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease. Mediators of Inflammation, 1998(), 137-140. https://doi.org/10.1080/09629359891036
Guo, Y., Zhou, G., He, C., Yang, W., He, Z., & Liu, Z. (2015). Serum Levels of Lipopolysaccharide and 1,3-β-D-Glucan Refer to the Severity in Patients with Crohn’s Disease. Mediators of Inflammation, 2015(), 487-495-445. https://doi.org/10.1155/2015/843089
Cekic, C., Kirci, A., Vatansever, S., Aslan, F., Yilmaz, H. E., Alper, E., Arabul, M., Yuksel, E. S., & Unsal, B. (2015). Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn\'s Disease. Gastroenterology Research and Practice, 2015(), 630-635-187. https://doi.org/10.1155/2015/850351
Nwosu, F. C., Thorkildsen, L. T., Avershina, E., Ricanek, P., Perminow, G., Brackmann, S., Vatn, M. H., & Rudi, K. (2013). Age-Dependent Fecal Bacterial Correlation to Inflammatory Bowel Disease for Newly Diagnosed Untreated Children. Gastroenterology Research and Practice, 2013(), 275-281-040. https://doi.org/10.1155/2013/302398
Cappello, M., Randazzo, C., Bravatà, I., Licata, A., Peralta, S., & Almasio, A. C. A. P. L. (2014). Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey. Clinical Medicine Insights: Gastroenterology, 2014(), 25-31. https://doi.org/10.4137/CGast.S13125